Everotas 0.5 mg Tablet
$10.01
$7.98
Everotas 0.5 mg Tablet is a targeted anticancer therapy designed to combat various advanced malignancies, including pancreatic, stomach, intestinal, and lung cancers that have metastasized and are not amenable to surgical intervention. This medication is particularly effective in treating postmenopausal women with advanced hormone receptor-positive and HER2-negative breast cancer, providing a vital option when traditional therapies are insufficient. In addition, Everotas is indicated for adult patients suffering from advanced kidney cancer, especially after prior treatments with sunitinib or sorafenib have failed. By inhibiting specific pathways involved in cancer cell growth and proliferation, Everotas helps to slow disease progression and improve patient outcomes. However, it is essential to note that this medication may lead to serious side effects, including liver toxicity and lung complications, which necessitate careful monitoring throughout treatment. Always consult a healthcare professional before starting Everotas to ensure it aligns with your individual treatment plan. With its unique mechanism of action and targeted approach, Everotas 0.5 mg Tablet is a crucial component in the fight against advanced cancer.
मात्रा
Active Pharmaceutical Ingredient
Uses
• Everotas 0.5 mg tablet is primarily indicated for the treatment of advanced hormone receptor-positive, HER2-negative breast cancer in postmenopausal women. This medication is often used in conjunction with exemestane after previous treatments with letrozole or anastrozole have proven ineffective. By targeting specific cancer pathways, Everotas 0.5 mg tablet helps to slow down the progression of the disease. Patients may experience a range of symptoms related to breast cancer, and this medication aims to alleviate some of those concerns.
• In the context of breast cancer treatment, Everotas 0.5 mg tablet plays a significant role in managing the disease when conventional therapies have failed. It is particularly beneficial for patients who have hormone receptor-positive tumors, as it works effectively to inhibit cancer cell growth. By incorporating Everotas 0.5 mg tablet into their treatment regimen, patients may find improved disease stability. This can lead to a better quality of life during their ongoing cancer journey.
• The use of Everotas 0.5 mg tablet is essential for postmenopausal women facing advanced stages of breast cancer. It offers a targeted approach to therapy, specifically designed for those with hormone receptor-positive, HER2-negative cancer types. By working alongside exemestane, Everotas 0.5 mg tablet enhances the overall effectiveness of the treatment plan. This combination can help manage symptoms and improve clinical outcomes for affected patients.
• Everotas 0.5 mg tablet is a valuable option for healthcare providers treating advanced breast cancer in postmenopausal women. Its role in combination therapy is crucial, especially after other treatments like letrozole or anastrozole have not yielded satisfactory results. This medication helps in mitigating the progression of cancer by targeting hormone receptors. Patients using Everotas 0.5 mg tablet may experience a more comprehensive approach to managing their condition.
Benefits
Everotas 0.5 mg Tablet is indicated to patients dealing with various cancers such as breast cancer, pancreatic cancer, lung cancer, kidney cancer and stomach/ intestinal cancer. Cancer of this type tends to spread quickly in other parts of the body. Everotas 0.5 mg Tablet travels through the bloodstream and effectively destroys cancerous cells and other parts of the body. It works by decreasing the activity of the immune system of the body and prevents the rejection of the transplanted organ. Everotas 0.5 mg works by stopping the action of an abnormal protein that causes the multiplication of cancerous cells. In this way, it stops the spread of cancerous cells. Besides this, it is also effective in people with genetic disorders to treat some types of tumours in the brain or kidneys.
Side Effects
Everotas 0.5 mg Tablet may cause some side effects. If you experience any of these side effects contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.
Most Common Side Effects
• Infection
• Urinary issues
• Hypertension, rise in cholesterol or triglycerides
• Stomach pain, nausea, diarrhoea and/or constipation
• Headache
• Swelling in your legs or feet
Common Side Effects
• Swelling in legs and feet
• Blood in stools and urine
• Burning sensation during urination
• Mouth sores
• Headache
• Tiredness
• Nausea
How To Use
Everotas 0.5 mg Tablet can be taken by mouth with or without food. Swallow the whole tablet with a glass of water. Do not crush, break, or chew the tablets. Take your dose around the same time every day. It is important to make sure you are taking the correct amount of medication every time. Before every dose, check that what you are taking matches what you have been prescribed. If you miss a dose and it has been less than 6 hours since your regular dose time, take it as soon as you remember. If it has been more than 6 hours, skip the dose. Do not take 2 doses at once to make up for a missed dose.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Everotas 0.5 mg Tablet. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Everotas 0.5 mg Tablet is safe to use in patients with kidney disease. No dose adjustment of Everotas 0.5 mg is recommended.
• Breastfeeding: It is not recommended to breastfeed while taking Everotas 0.5 mg. Everotas 0.5 mg Tablet may pass into breast milk and harm the infant. If you are breastfeeding and taking Everotas 0.5 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Everotas 0.5 mg Tablet should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Everotas 0.5 mg and report any unusual symptoms or changes in liver function to their doctor. The dose of Everotas 0.5 mg may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Everotas 0.5 mg Tablet may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Everotas 0.5 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Everotas 0.5 mg Tablet may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Everotas 0.5 mg.